Magnetic resonance imaging for lung cancer

Journal of Thoracic Imaging

Volumn 28, Issue 3, 2013, Pages 138-150

  Koyama, Hisanobu ^a   Ohno, Yoshiharu ^a   Seki, Shinichiro ^a   Nishio, Mizuho ^a   Yoshikawa, Takeshi ^a   Matsumoto, Sumiaki ^a   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2 deoxy 2 18F fluoro D glucose positron emission tomography; Computed tomography; Lung cancer; Magnetic resonance imaging

Indexed keywords

BEVACIZUMAB; CISPLATIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE;

BRAIN METASTASIS; BREATHING PATTERN; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; GLUCOSE METABOLISM; HUMAN; IMAGE QUALITY; IONIZING RADIATION; LUNG CANCER; LUNG FUNCTION; LUNG METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; RADIATION EXPOSURE; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877010474     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0b013e31828d4234     Document Type: Conference Paper

References (80)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108
2. Sieren JC, Ohno Y, Koyama H, et al. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging. 2010;32:1353-1369
3. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178:705-713
4. Koyama H, Ohno Y, Kono A, et al. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol. 2008;18:2120-2131
5. Ohno Y, Hatabu H, Takenaka D, et al. Solitary pulmonary nodules: Potential role of dynamic MR imaging in management: Initial experience. Radiology. 2002;224:503-511
6. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging -perfusion differences in malignant and benign lesions. Radiology. 2004; 232:544-553
7. Biederer J, Schoene A, Freitag S, et al. Simulated pulmonary nodules implanted in a dedicated porcine chest phantom: Sensitivity of MR imaging for detection. Radiology. 2003; 227:475-483
8. Regier M, Kandel S, Kaul MG, et al. Detection of small pulmonary nodules in high-field MR at 3 T: Evaluation of different pulse sequences using porcine lung explants. Eur Radiol. 2007;17:1341-1351
9. Schroeder T, Ruehm SG, Debatin JF, et al. Detection of pulmonary nodules using a 2D HASTE MR sequence: Comparison with MDCT. Am J Roentgenol. 2005;185:979-984
10. Both M, Schultze J, Reuter M, et al. Fast T1-And T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma. Eur J Radiol. 2005;53:478-488
11. Frericks BB, Meyer BC, Martus P, et al. MRI of the thorax during whole-body MRI: Evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT). J Magn Reson Imaging. 2008;27: 538-545
12. Yi CA, Jeon TY, Lee KS, et al. 3-T MRI: Usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors. Am J Roentgenol. 2007;189: 386-392
13. Bruegel M, Gaa J, Woertler K, et al. MRI of the lung: Value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases. J Magn Reson Imaging. 2007;25:73-81
14. Chen W, Jian W, Li HT, et al. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Magn Reson Imaging. 2010;28:613-620
15. Koyama H, Ohno Y, Aoyama N, et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: Capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol. 2010;20:790-800
16. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: Five-year prospective experience. Radiology. 2005;235: 259-265
17. Bach PB, Silvestri GA, Hanger M, et al. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:69S-77S.
18. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: A statement from the Fleischner Society. Radiology. 2005;237:395-400
19. Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: When is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:94S-107S.
20. Jeong YJ, Lee KS, Jeong SY, et al. Solitary pulmonary nodule: Characterization with combined washin and washout features at dynamic multi-detector row CT. Radiology. 2005;237: 675-683
21. Higashi K, Ueda Y, Sakuma T, et al. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med. 2001;42:1489-1496
22. Kusumoto M, Kono M, Adachi S, et al. Gadopentetatedimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma. Invest Radiol. 1994;29:S255-S256
23. Schaefer JF, Schneider V, Vollmar J, et al. Solitary pulmonary nodules: Association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer. 2006;53:39-49
24. Kono R, Fujimoto K, Terasaki H, et al. Dynamic MRI of solitary pulmonary nodules: Comparison of enhancement patterns of malignant and benign small peripheral lung lesions. Am J Roentgenol. 2007;188:26-36
25. Ohno Y, Koyama H, Takenaka D, et al. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucosepositron emission tomography (FDG-PET)/CT: Comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging. 2008;27:1284-1295
26. Sakai F, Sone S, Maruyama A, et al. Thin-rim enhancement in Gd-DTPA-enhanced magnetic resonance images of tuberculoma: A new finding of potential differential diagnostic importance. J Thorac Imaging. 1992;7:64-69
27. Gaeta M, Vinci S, Minutoli F, et al. CT and MRI findings of mucin-containing tumors and pseudotumors of the thorax: Pictorial review. Eur Radiol. 2002;12:181-189
28. Sakai F, Sone S, Kiyono K, et al. MR of pulmonary hamartoma: Pathologic correlation. J Thorac Imaging. 1994;9: 51-55
29. Fujimoto K, Meno S, Nishimura H, et al. Aspergilloma within cavitary lung cancer: MR imaging findings. Am J Roentgenol. 1994;163:565-567
30. Shioya S, Haida M, Ono Y, et al. Lung cancer: Differentiation of tumor, necrosis, and atelectasis by means of T1 and T2 values measured in vitro. Radiology. 1988;167: 105-109
31. Satoh S, Kitazume Y, Ohdama S, et al. Can malignant and benign pulmonary nodules be differentiated with diffusionweighted MRI? Am J Roentgenol. 2008;191:464-470
32. Liu H, Liu Y, Yu T, et al. Usefulness of diffusionweighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol. 2010;20:807-815
33. Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology. 2009;252:247-254
34. Mori T, Nomori H, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: Comparison with positron emission tomography. J Thorac Oncol. 2008;3:358-364
35. Quint LE, Francis IR. Radiologic staging of lung cancer. J Thorac Imaging. 1999;14:235-246
36. Glazer HS, Kaiser LR, Anderson DJ, et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology. 1989;173:37-42
37. White PG, Adams H, Crane MD, et al. Preoperative staging of carcinoma of the bronchus: Can computed tomographic scanning reliably identify stage III tumours? Thorax. 1994; 49:951-957
38. Ohno Y, Adachi S, Motoyama A, et al. Multiphase ECGtriggered 3D contrast-enhanced MR angiography: Utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging. 2001;13:215-224
39. Yi CA, Shin KM, Lee KS, et al. Non-small cell lung cancer staging: Efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology. 2008;248:632-642
40. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: Evaluation with MR imaging. Radiology. 1993;187:33-38
41. Freundlich IM, Chasen MH, Varma DG. Magnetic resonance imaging of pulmonary apical tumors. J Thorac Imaging. 1996; 11:210-222
42. Sakai S, Murayama S, Murakami J, et al. Bronchogenic carcinoma invasion of the chest wall: Evaluation with dynamic cine MRI during breathing. J Comput Assist Tomogr. 1997;21:595-600
43. Murata K, Takahashi M, Mori M, et al. Chest wall and mediastinal invasion by lung cancer: Evaluation with multisection expiratory dynamic CT. Radiology. 1994;191:251-255
44. Dillemans B, Deneffe G, Verschakelen J, et al. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients. Eur J Cardiothorac Surg. 1994;8:37-42
45. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319-323
46. Webb WR, Sarin M, Zerhouni EA, et al. Interobserver variability in CT and MR staging of lung cancer. J Comput Assist Tomogr. 1993;17:841-846
47. Patz EF Jr, Lowe VJ, Goodman PC, et al. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest. 1995;108:1617-1621
48. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest. 2000;117:773-778
49. Boiselle PM, Patz EF Jr, Vining DJ, et al. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics. 1998;18:1061-1069
50. Ohno Y, Hatabu H, Takenaka D, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: Quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology. 2004;231: 872-879
51. Ohno Y, Koyama H, Nogami M, et al. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: Quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging. 2007;26:1071-1080
52. Nomori H, Mori T, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg. 2008;135:816-822
53. Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: Quantitative assessment with diffusionweighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr. 2010;34:1-8
54. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial. Lancet. 2002;359:1388-1393
55. Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: Evaluation of patients for metastases. Radiology. 2004;233:139-148
56. Goehde SC, Hunold P, Vogt FM, et al. Full-body cardiovascular and tumor MRI for early detection of disease: Feasibility and initial experience in 298 subjects. Am J Roentgenol. 2005;184:598-611
57. Ohno Y, Koyama H, Nogami M, et al. Whole-body MR imaging vs. FDG-PET: Comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging. 2007;26:498-509
58. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: Whole-body MR examination for M-stage assessment -utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology. 2008;248:643-654
59. Sommer G, Wiese M, Winter L, et al. Preoperative staging of non-small-cell lung cancer: Comparison of whole-body diffusionweighted magnetic resonance imaging and (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol. 2012;22:2859-2867
60. Golebiowski A. Pulmonary resection in patients over 70 years old age. J Thorac Cardiovasc Surg. 1971;61:265-270
61. Legge JS, Palmer KNV. Pulmonary function in bronchial carcinoma. Thorax. 1973;28:588-591
62. Imaeda T, Kanematu M, Asada S, et al. Prediction of pulmonary function after resection of primary lung cancer: Utility of inhalation/perfusion SPECT imaging. Clin Nucl Med. 1995;20:792-799
63. Konietzko N. Nuclear medicine techniques in the management of bronchogenic carcinoma. Eur J Nucl Med. 1987;13:S16-S19
64. Hayes M, Taplin GV. Lung imaging with radioaerosols for the assessment of airway disease. Semin Nucl Med. 1980;10: 243-251
65. Bolliger CT, Guckel C, Engel H, et al. Prediction of functional reserves after lung resection: Comparison comparison between quantitative computed tomography, scintigraphy, and anatomy. Respiration. 2002;69:482-489
66. Ohno Y, Hatabu H, Higashino T, et al. Dynamic perfusion MRI versus perfusion scintigraphy: Prediction of postoperative lung function in patients with lung cancer. Am J Roentgenol. 2004;182:73-78
67. Ohno Y, Koyama H, Nogami M, et al. Postoperative lung function in lung cancer patients: Comparative analysis of predictive capability of MRI, CT, and SPECT. Am J Roentgenol. 2007;189:400-408
68. Salerno M, Altes TA, Brookeman JR, et al. Dynamic spiral MRI of pulmonary gas flow using hyperpolarized (3)He: Preliminary studies in healthy and diseased lungs. Magn Reson Med. 2001;46:667-677
69. Salerno M, de Lange EE, Altes TA, et al. Emphysema: Hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes -initial experience. Radiology. 2002;222:252-260
70. Ohno Y, Hatabu H, Higashino T, et al. Oxygen-enhanced MR imaging: Correlation with postsurgical lung function in patients with lung cancer. Radiology. 2005;236:704-711
71. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205-216
72. de Geus-Oei LF, van der Heijden HF, Visser EP, et al. Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer. J Nucl Med. 2007; 48:1592-1598
73. Wang J, Wu N, Cham MD, et al. Tumor response in patients with advanced non-small cell lung cancer: Perfusion CT evaluation of chemotherapy and radiation therapy. Am J Roentgenol. 2009;193:1090-1096
74. Weber WA, Petersen V, Schmidt B, et al. Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol. 2003;21:2651-2657
75. Lee DH, Kim SK, Lee HY, et al. Early prediction of response to first-line therapy using using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer. J Thorac Oncol. 2009;4:816-821
76. Ohno Y, Nogami M, Higashino T, et al. Prognostic value of dynamicMR imaging for non-small-cell lung cancer patients after chemoradiotherapy. J Magn Reson Imaging. 2005;21:775-783
77. Chang YC, Yu CJ, Chen CM, et al. Dynamic contrastenhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin. J Magn Reson Imaging. 2012;36:387-396
78. Ohno Y, Koyama H, Yoshikawa T, et al. Diffusion-weighted MRI versus 18F-FDG PET/CT: Performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. Am J Roentgenol. 2012;198:75-82
79. Yabuuchi H, Hatakenaka M, Takayama K, et al. Non-small cell lung cancer: Detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. Radiology. 2011;261:598-604
80. Chang Q, Wu N, Ouyang H, et al. Diffusion-weighted magnetic resonance imaging of lung cancer at 3.0 T: A preliminary study on monitoring diffusion changes during chemoradiation therapy. Clin Imaging. 2012;36:98-103